2024 marked 10 years since we launched Open Philanthropy. We spent our first decade learning (about grantmaking, cause selection, and the history of philanthropy), and growing our team and expertise to be able to effectively deploy billions of dollars from Good Ventures, our main funder. Our early grants — and some grantees we’ve helped get started — are now old enough that we can see material signs of our impact in the world.

The start of our second decade also marked a major change in our direction. With Good Ventures approaching the level of spending consistent with its founders’ ambition to spend down in their lifetimes, we finally began to execute at scale on our long-held ambition to support other funders, and found a surprising degree of early success. I expect that our ambition to serve additional partners will guide much of our second decade.

A few highlights from the year:

  • We launched the Lead Exposure Action Fund (LEAF), a >$100 million collaborative fund to reduce lead exposure globally. LEAF marked our first major foray into partnering with other funders beyond Good Ventures, and we’re planning to do a lot more in this vein going forward — more below.
  • Our longtime grantee David Baker won the Nobel Prize in Chemistry for his groundbreaking work using AI for protein design. We’re proud to have supported both the basic methods development and the potentially high-impact humanitarian applications of his work for ailments like syphilis, hepatitis C, snakebite, and malaria.
  • Our grantee Open New York played an important role in the recent passage of New York City’s largest zoning overhaul in over 60 years. The city planning department expects the package to create 80,000 new homes over 15 years, making this the first set of major YIMBY reforms to pass in New York City.
  • Research mentorship programs that we fund continue to produce some of the top technical talent in AI safety and security. Graduates of programs like MATS, the Astra Fellowship, LASR Labs, and ERA-AI have contributed to key safety areas like interpretability, evaluations, and loss of control. For instance, MATS now trains more than 100 aspiring AI safety researchers annually, some of whom rapidly contribute to the field: a recent graduate received “Best Paper” at one of the leading AI conferences.
  • Our grantee, the Mirror Biology Dialogues Fund, brought attention to the unprecedented risks of creating mirror bacteria, working alongside a group of 30+ esteemed scientists (including two Nobel laureates). Their work was published in Science along with a 300-page technical report detailing the risks.
  • We directed $87 million to GiveWell-recommended charities. We continue to think that these charities are among the highest-value uses of philanthropic money, and we are proud to support their work on malaria, vitamin A deficiency, childhood vaccination, and more.

For more examples of interesting work we supported, check out this blog post. The rest of this update:

  • Offers brief updates on grantmaking from each of our programs.
  • Reflects on a few themes from the year including:
    • Appointing a new leadership team.
    • Building new partnerships.
    • Tracking continued rapid progress on AI.
  • Looks forward to the rest of 2025.

As always, I welcome feedback. You can find me on Twitter/X or Bluesky, or email us at info@openphilanthropy.org.


You can read the rest of this post at Open Philanthropy's website.
 

Comments2


Sorted by Click to highlight new comments since:

This is so epic, keep up the good work!

I followed you.

Curated and popular this week
LintzA
 ·  · 15m read
 · 
Cross-posted to Lesswrong Introduction Several developments over the past few months should cause you to re-evaluate what you are doing. These include: 1. Updates toward short timelines 2. The Trump presidency 3. The o1 (inference-time compute scaling) paradigm 4. Deepseek 5. Stargate/AI datacenter spending 6. Increased internal deployment 7. Absence of AI x-risk/safety considerations in mainstream AI discourse Taken together, these are enough to render many existing AI governance strategies obsolete (and probably some technical safety strategies too). There's a good chance we're entering crunch time and that should absolutely affect your theory of change and what you plan to work on. In this piece I try to give a quick summary of these developments and think through the broader implications these have for AI safety. At the end of the piece I give some quick initial thoughts on how these developments affect what safety-concerned folks should be prioritizing. These are early days and I expect many of my takes will shift, look forward to discussing in the comments!  Implications of recent developments Updates toward short timelines There’s general agreement that timelines are likely to be far shorter than most expected. Both Sam Altman and Dario Amodei have recently said they expect AGI within the next 3 years. Anecdotally, nearly everyone I know or have heard of who was expecting longer timelines has updated significantly toward short timelines (<5 years). E.g. Ajeya’s median estimate is that 99% of fully-remote jobs will be automatable in roughly 6-8 years, 5+ years earlier than her 2023 estimate. On a quick look, prediction markets seem to have shifted to short timelines (e.g. Metaculus[1] & Manifold appear to have roughly 2030 median timelines to AGI, though haven’t moved dramatically in recent months). We’ve consistently seen performance on benchmarks far exceed what most predicted. Most recently, Epoch was surprised to see OpenAI’s o3 model achi
Dr Kassim
 ·  · 4m read
 · 
Hey everyone, I’ve been going through the EA Introductory Program, and I have to admit some of these ideas make sense, but others leave me with more questions than answers. I’m trying to wrap my head around certain core EA principles, and the more I think about them, the more I wonder: Am I misunderstanding, or are there blind spots in EA’s approach? I’d really love to hear what others think. Maybe you can help me clarify some of my doubts. Or maybe you share the same reservations? Let’s talk. Cause Prioritization. Does It Ignore Political and Social Reality? EA focuses on doing the most good per dollar, which makes sense in theory. But does it hold up when you apply it to real world contexts especially in countries like Uganda? Take malaria prevention. It’s a top EA cause because it’s highly cost effective $5,000 can save a life through bed nets (GiveWell, 2023). But what happens when government corruption or instability disrupts these programs? The Global Fund scandal in Uganda saw $1.6 million in malaria aid mismanaged (Global Fund Audit Report, 2016). If money isn’t reaching the people it’s meant to help, is it really the best use of resources? And what about leadership changes? Policies shift unpredictably here. A national animal welfare initiative I supported lost momentum when political priorities changed. How does EA factor in these uncertainties when prioritizing causes? It feels like EA assumes a stable world where money always achieves the intended impact. But what if that’s not the world we live in? Long termism. A Luxury When the Present Is in Crisis? I get why long termists argue that future people matter. But should we really prioritize them over people suffering today? Long termism tells us that existential risks like AI could wipe out trillions of future lives. But in Uganda, we’re losing lives now—1,500+ die from rabies annually (WHO, 2021), and 41% of children suffer from stunting due to malnutrition (UNICEF, 2022). These are preventable d
Paul Present
 ·  · 28m read
 · 
Note: I am not a malaria expert. This is my best-faith attempt at answering a question that was bothering me, but this field is a large and complex field, and I’ve almost certainly misunderstood something somewhere along the way. Summary While the world made incredible progress in reducing malaria cases from 2000 to 2015, the past 10 years have seen malaria cases stop declining and start rising. I investigated potential reasons behind this increase through reading the existing literature and looking at publicly available data, and I identified three key factors explaining the rise: 1. Population Growth: Africa's population has increased by approximately 75% since 2000. This alone explains most of the increase in absolute case numbers, while cases per capita have remained relatively flat since 2015. 2. Stagnant Funding: After rapid growth starting in 2000, funding for malaria prevention plateaued around 2010. 3. Insecticide Resistance: Mosquitoes have become increasingly resistant to the insecticides used in bednets over the past 20 years. This has made older models of bednets less effective, although they still have some effect. Newer models of bednets developed in response to insecticide resistance are more effective but still not widely deployed.  I very crudely estimate that without any of these factors, there would be 55% fewer malaria cases in the world than what we see today. I think all three of these factors are roughly equally important in explaining the difference.  Alternative explanations like removal of PFAS, climate change, or invasive mosquito species don't appear to be major contributors.  Overall this investigation made me more convinced that bednets are an effective global health intervention.  Introduction In 2015, malaria rates were down, and EAs were celebrating. Giving What We Can posted this incredible gif showing the decrease in malaria cases across Africa since 2000: Giving What We Can said that > The reduction in malaria has be
Recent opportunities in Building effective altruism